Cutaneous Pseudolymphoma With Langerhans Cell Hyperplasia-A Rare Case With Clinical Presentation Mimicking Malignancy and Potential Diagnostic Pitfall.
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
pubmed:
19
5
2021
medline:
26
2
2022
entrez:
18
5
2021
Statut:
ppublish
Résumé
We describe a rare case of cutaneous pseudolymphoma with Langerhans cell hyperplasia. An 84-year-old female patient presented with erythematous and pernicious-looking plaques on her scalp that had been present for months. Histologically, lymphoid follicles consisting of mixed-type lymphocytes and Langerhans cells were aggregated focally. The diagnosis was verified by several immunohistochemical stains and by clinical evaluation. Skin lesions were steadily resolved with low-dose corticosteroid and hydroxychloroquine.
Identifiants
pubmed: 34001745
doi: 10.1097/DAD.0000000000001984
pii: 00000372-202112000-00070
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e280-e284Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Mitteldorf C, Kempf W. Cutaneous pseudolymphoma. Surg Pathol Clin. 2017;10:455–476.
Mitteldorf C, Kempf W. Cutaneous pseudolymphoma—a review on the spectrum and a proposal for a new classification. J Cutan Pathol. 2020;47:76–97.
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: a systematic review. Acta Derm Venereol. 2018;98:310–317.
Hatter AD, Zhou X, Honda K, et al. Langerhans cell hyperplasia from molluscum contagiosum. Am J Dermatopathol. 2015;37:e93–e95.
Pigozzi B, Bordignon M, Fortina AB, et al. Expression of the CD1a molecule in band T-lymphoproliferative skin conditions. Oncol Rep. 2006;15:347–351.
Grace SA, Sutton AM, Armbrecht ES, et al. p53 is a helpful marker in distinguishing Langerhans cell histiocytosis from Langerhans cell hyperplasia. Am J Dermatopathol. 2017;39:726–730.
Christie LJ, Evans AT, Bray SE, et al. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Hum Pathol. 2006;37:32–39.
Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol. 1994;13:187–196.
Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38(pt 1):877–895.
Kempf W, Kerl H, Kutzner H. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: a crucial role and a new lymphoma paradigm. Am J Dermatopathol. 2009;32:194–196.
Kutzner H, Kerl H, Pfaltz MC, et al. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol. 2009;33:1307–1313.
Rainsford KD, Parke AL, Clifford-Rashotte M, et al. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology. 2015;23:231–269.